World TB Day collection

Elsevier

Although the number of deaths worldwide from tuberculosis—a disease caused by the bacterium Mycobacterium tuberculosis—fell by 22% between 2000 and 2015, it remains humanity’s biggest infectious killer and one of the top ten causes of all deaths. The 2016 WHO Global Tuberculosis Report estimated that in 2015 there were 10.4 million new tuberculosis cases and 1.4 million deaths. The interaction between tuberculosis and HIV is important, with an estimated 400 000 additional deaths occurring among people with co-infection. Perhaps most troubling, is that the new cases of tuberculosis include about 480 000 people with the multidrug-resistant form of the disease—that is, resistant to treatment with two of the first-line medications against tuberculosis, isoniazid and rifampicin. Only about 20% of people newly eligible for treatment for multidrug-resistant tuberculosis in 2015 were enrolled in treatment. One of the UN Sustainable Development Goals for 2030 is a 90% reduction in tuberculosis deaths and 80% reduction in new cases (incidence) compared with 2015. However, the current annual rate of decline of incidence is only 1.5% and needs to reach 4–5% for the milestone to be achieved. Furthermore, unless investment in tuberculosis treatment and prevention increases, there will be a US$6 billion funding gap by 2020. Tuberculosis remains a treatable disease—even the multidrug-resistant form, albeit with a complex and time-consuming drug regimen. Although it is primarily a disease of poor and disadvantaged people, everyone on Earth is potentially at risk of tuberculosis. World TB Day is an opportunity to highlight the challenges—and opportunities—to achieve the goal of controlling tuberculosis through sustained prevention, detection, and treatment.

March 24, 2017
Year of publication
2017
Resource types
Journal and research articles
Tags
TB, tuberculosis, TB-HIV co-infection, multidrug-resistant TB (MDR-TB), treatment, TB prevention, World TB Day

Similar Resources

Tuberculosis disproportionately affects hard-to-reach populations, such as homeless people, migrants, refugees, prisoners, or drug users. These people often face challenges in accessing quality health care.

The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics…

Adolescents newly diagnosed with HIV need to be rapidly incorporated into HIV care networks to have the best chances of remaining in care in the long term, research from the United States published in the June 1st edition of the Journal of Acquired Immune Deficiency Syndromes shows.

BACKGROUND:

Attrition along the HIV care continuum slows gains in mitigating the South African HIV epidemic. Understanding population-level gaps in HIV identification, linkage, retention in care and viral suppression is critical to target programming.

BACKGROUND:

The goal of virtual elimination of horizontal and mother-to-child HIV transmission in South Africa (SA) has been proposed, but there have been few systematic investigations of which interventions are likely to be most critical to reducing HIV incidence.

In this report, UNAIDS is announcing that 18.2 million people now have access to HIV treatment. The Fast-Track response is working. Increasing treatment coverage is reducing AIDS-related deaths among adults and children. But the life-cycle approach has to include more than just treatment.

Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resistant or rifampicin-resistant (MDR/RR), which is often interpreted as evidence that drug resistance results mainly from poor treatment adherence.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.